SCHEMBL6504545

SCHEMBL6504545

CN(C)c1ccc(C=O)cc1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.44
NOTUM Q6P988 1/20 0.43
CYP2A6 P11509 2/20 0.42
CYP2A13 Q16696 1/20 0.42
ALDH1A3 P47895 3/20 0.40
ALDH3A1 P30838 4/20 0.38
ALDH1A1 P00352 3/20 0.38
AKR1C3 P42330 1/20 0.37
AKR1C2 P52895 1/20 0.37
TSHR P16473 1/20 0.35
APP P05067 4/20 0.35
CRHR1 P34998 1/20 0.35
KDM4E B2RXH2 1/20 0.34
PTGS2 P35354 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2098999 0.84 CYP2A6 (0.44) CYP2A6CYP2A13ALDH1A3ALDH3A1ALDH1A1
SCHEMBL6500670 0.78 APP (0.48) ALDH1A1AKR1C3AKR1C2TSHRAPP
SCHEMBL6500667 0.78 APP (0.48) ALDH1A1AKR1C3AKR1C2TSHRAPP
SCHEMBL472408 0.77 KIF11 (0.56) KIF11CYP2A6ALDH1A1AKR1C3AKR1C2
SCHEMBL27694001 0.77 CYP2A6 (0.52) CYP2A6CYP2A13ALDH1A3ALDH3A1ALDH1A1
SCHEMBL24818962 0.76 ERN1 (0.39) KIF11CYP2A6CYP2A13AKR1C3AKR1C2
SCHEMBL3186339 0.76 CYP2A6 (0.47) KIF11CYP2A6CYP2A13ALDH1A3ALDH3A1
SCHEMBL1769710 0.76 KIF11 (0.47) KIF11NOTUMCYP2A6ALDH1A3ALDH1A1
SCHEMBL6855509 0.75 KIF11 (0.50) KIF11CYP2A6ALDH1A3ALDH1A1AKR1C3
SCHEMBL28818187 0.75 KIF11 (0.41) KIF11CYP2A6CYP2A13ALDH1A3AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed